Durham, North Carolina, United States The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the Durham.
We also calculated 4 valuable employees in our database.
Among the most popular fund investment industries, there are Therapeutics, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight CeNeRx BioPharma, Dynogen Pharmaceuticals, BrainCells. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the A. M. Pappas & Associates, startups are often financed by Wakefield Group, Sears Capital Management, Perseus-Soros Biopharmaceutical Fund. The meaningful sponsors for the fund in investment in the same round are Montreux Equity Partners, Domain Associates, Canaan Partners. In the next rounds fund is usually obtained by Pappas Ventures, Wellcome Trust, Varian.
The average startup value when the investment from A. M. Pappas & Associates is 10-50 millions dollars. Considering the real fund results, this Corporate Investor is 3 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2002. The fund is generally included in less than 2 deals every year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2013. Opposing the other organizations, this A. M. Pappas & Associates works on 21 percentage points more the average amount of lead investments.
Related Funds
| Fund Name | Location |
| AlphaBlock Capital | - |
| Beyond X | Chiyoda, Japan |
| BW Offshore | Norway, Oslo |
| Cartera de Inversiones CM | Barcelona, Catalonia, Spain |
| CMT Digital Ventures LLC | Chicago, Illinois, United States |
| Crystal-Optech | China, Hangzhou, Zhejiang |
| DB Capital Ventures | New York, New York, United States |
| Essel Finance | India, Maharashtra, Mumbai |
| Federman Capital | Boston, Massachusetts, United States |
| Future Invest | China, Hangzhou, Zhejiang |
| Halliburton Energy Services | Houston, Texas, United States |
| Health 100 | China, Shanghai, Xuhui |
| HumanCo | New York, New York, United States |
| Metallavon VC | - |
| Old Ironsides Energy | Boston, Massachusetts, United States |
| Securian Ventures | Minnesota, Saint Paul, United States |
| Shenzhen Yizan Investment Management | China, Guangdong, Shenzhen |
| Social Impact Fund | - |
| Sunnybrook Research Institute | - |
| Treasure Valley Angel Fund | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $15M | 29 Sep 2008 | Cary, North Carolina, United States | |||
Cerexa Inc. | $50M | 23 Aug 2005 | New York, New York, United States | ||
BrainCells | $17M | 15 Jul 2005 | San Diego, California, United States | ||
Plexxikon | $46M | 26 May 2004 | Berkeley, California, United States | ||
Peninsula Pharmaceuticals | $57M | 16 Jan 2004 | California, United States | ||
Selventa | $6M | 08 Sep 2003 | Cambridge, Massachusetts, United States | ||
Dynogen Pharmaceuticals | $13M | 15 Nov 2002 | Boston, Massachusetts, United States | ||
Peninsula Pharmaceuticals | $22M | 28 Oct 2002 | California, United States | ||
Syntonix Pharmaceuticals | $35M | 01 Feb 2002 | Waltham, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $15M | 29 Sep 2008 | Cary, North Carolina, United States | |||
Cerexa Inc. | $50M | 23 Aug 2005 | New York, New York, United States | ||
BrainCells | $17M | 15 Jul 2005 | San Diego, California, United States | ||
Plexxikon | $46M | 26 May 2004 | Berkeley, California, United States | ||
Peninsula Pharmaceuticals | $57M | 16 Jan 2004 | California, United States | ||
Selventa | $6M | 08 Sep 2003 | Cambridge, Massachusetts, United States | ||
Dynogen Pharmaceuticals | $13M | 15 Nov 2002 | Boston, Massachusetts, United States | ||
Peninsula Pharmaceuticals | $22M | 28 Oct 2002 | California, United States | ||
Syntonix Pharmaceuticals | $35M | 01 Feb 2002 | Waltham, Massachusetts, United States |
